Table: begin end state 1 6 cytoplasmic 7 25 transmembrane 26 30 non-cytoplasmic 31 48 transmembrane 49 54 cytoplasmic 55 72 transmembrane 73 87 non-cytoplasmic 88 108 transmembrane 109 115 cytoplasmic 116 140 transmembrane 141 146 non-cytoplasmic 147 166 transmembrane 167 177 cytoplasmic 178 203 transmembrane 204 218 non-cytoplasmic 219 241 transmembrane 242 272 cytoplasmic 273 291 transmembrane 292 296 non-cytoplasmic 297 315 transmembrane 316 326 cytoplasmic 327 349 transmembrane 350 361 non-cytoplasmic 362 381 transmembrane 382 387 cytoplasmic 388 415 transmembrane 416 444 non-cytoplasmic 445 468 transmembrane 469 477 cytoplasmic
Input: >BWI76_RS04375 MQKNKLWKLLVIIAIPLLISLFPAPEGLSKLAWVLSGIYLAAIVGLVIKPFAEPVVLLIA VAASMVVVGNLGDGSIKAASVLSGYSSGTTWLVFSAFTLSAAFVITGLGKRIAYILIGKI GSTTLGLGYVTAFLDLILAPATPSNTARAGGIVLPIINSVAVALGSEPERSAKRVGHYLM LNVYMVTKTTSYMFFTAMAGNILALKMIEDICHIKLSWGGWALAAGLPGIIMLLLTPLIT YKLYPPELKKVDNKKIAKAGMEALGPMTLREKMLSCLFVLALGGWVFSQSLGVNESTVAI GVMALMLVLRIVTWDDVIKNKGGWNTLIWYGGIIGLSSLLSKVGFFLWLADLLKNNISFN GHGNVAFIVIVALSILVRYFFASGSAYIVAMVPVFAMLANVSGAPVMLTALALLFSNSYG GMVTHYGGAAGPVIFGVGYNDIKSWWIIGGILALLTFLLQITLGVWWWEILIAWKVI
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server